Paasa Logo
Perseus Proteomics Inc. logo
4882JPXMarket closedOpens 9:00am JST

Perseus Proteomics Inc.

¥153.00Last updated
+¥3.00 (2.00%)Past day
Timezone

Perseus Proteomics Inc. (JPX: 4882) is trading at ¥153.00, about ₹94 at today's JPY/INR rate, as of 9 Oct 2026, 2:30 AM ET, up 2.00% today. Indian residents can buy Perseus Proteomics from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:¥150.00
Previous close:¥150.00
Volume:97.20K

Today's low

¥150.00

Today's high

¥155.00

52 week low

¥134.00

52 week high

¥340.00

4882 opened at ¥150.00, closed previously at ¥150.00, and has traded between ¥134.00 and ¥340.00 over the past 52 weeks.

About

Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.

Country
JP
CEO
Takuya Yokokawa
Exchange listed on
JPX
Industry
Drug Manufacturers - General
Base currency
JPY
Full Time Employees
35
Sector
Healthcare
IPO date
22/06/2021

Key statistics

Avg. volume

591.06K

Market cap

¥2.82B

P/E Ratio

-3.18

Price-to-sales ratio

19.15

Enterprise value

¥1.76B

Free cash flow yield

-20.21%

Debt-to-equity ratio

0.00

Return on equity

-58.97%

ROIC

-47.81%

Beta

0.32

Dividend yield

0.00%

Last dividend

¥0.00

Financial overview

Revenue

¥135.51M

Earnings per share

-¥48.17

Free cash flow

-¥662.83M

Net profit margin

-505.80%

Gross margin

85.92%

EBITDA

-¥715.80M

Revenue growth

12.57%

Similar securities

This is not an investment recommendation

How to buy Perseus Proteomics from India

Indian residents can buy Perseus Proteomics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in Perseus Proteomics from India

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to JPY.

  3. Search for Perseus Proteomics and place an order

    Find Perseus Proteomics by name or by its ticker, 4882, and choose an order type. The Tokyo Stock Exchange typically trades in units of 100 shares. Perseus Proteomics trades 5:30 am – 12:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Perseus Proteomics position in JPY and INR. Perseus Proteomics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Trading and taxes when buying Perseus Proteomics from India

Trading and limits

Trading hours
9:00 am – 3:30 pm JST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NonePerseus Proteomics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Estate or inheritance tax
May applyJapan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir.Estate tax explained

FAQs

Can Indian residents buy Perseus Proteomics stock?

Yes. Perseus Proteomics (4882) has been listed on the Tokyo Stock Exchange since 2021, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to JPY. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Perseus Proteomics share cost in rupees?

One Perseus Proteomics share is ¥153.00 — about ₹94 at a JPY/INR rate of 0.6120 on 9 Oct 2026. Both the Perseus Proteomics price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Perseus Proteomics from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Perseus Proteomics?

The Tokyo Stock Exchange typically trades in units of 100 shares.

How are gains on Perseus Proteomics shares taxed in India?

Japan generally does not levy capital gains tax on non-resident individual investors, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the JPY/INR rate on the purchase and the sale date, so the rupee move counts alongside the Perseus Proteomics price. Paasa issues a capital-gains statement for your return.

Does Perseus Proteomics pay a dividend?

No. Perseus Proteomics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Perseus Proteomics from India?

The Tokyo Stock Exchange trades 5:30 am – 12:00 pm IST in Indian time. It also halts for lunch, 8:00 am – 9:00 am IST. Orders can only execute during that window.

Is there estate or inheritance tax on Perseus Proteomics shares held from India?

Japan levies inheritance tax on Japan-located assets such as direct stocks, with an exemption of ¥30 million plus ¥6 million per statutory heir. It applies to your overall holdings in that jurisdiction rather than to any one position.

Do I have to declare Perseus Proteomics shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Perseus Proteomics holding, its cost and its closing value.

How do I sell Perseus Proteomics and bring the money back to India?

You sell during market hours (5:30 am – 12:00 pm IST) and the proceeds settle in JPY in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.